Why the study?
Does inhibition of nitric oxide synthesis prevent flow-induced endothelium-dependent arterial dilatation in cats?
Does inhibition of nitric oxide synthesis prevent flow-induced endothelium-dependent arterial dilatation in cats?
Flow-induced endothelium-dependent arterial dilatation in the feline femoral artery is not mediated by nitric oxide derived from L-arginine.
Flow-induced dilatation is NO-independent in this feline model; leaves open endothelial mechanisms and human relevance.
OBJECTIVE: The aim was to determine whether the endothelium derived nitric oxide formed from L-arginine is the factor which mediates flow induced dilatation of conduit arteries. METHODS: Changes in diameter of feline femoral artery caused by blood flow rate increases, acetylcholine, and ATP were recorded during perfusion with blood in situ before and after the inhibition of endothelium derived nitric oxide synthesis by NG-nitro-L-arginine methyl ester and NG-monomethyl-L-arginine. Fourteen anaesthetised cats of either sex, weight 2.6-3.9 kg, were used for the studies. RESULTS: Intravenous administration of NG-nitro-L-arginine methyl ester and NG-monoethyl-L-arginine in doses 10 and 30 mg.kg-1 evoked a rise in mean systemic arterial pressure, constriction of the femoral artery, and considerable decrease in acetylcholine and ATP induced dilatation. However, it did not affect the dilator response induced by increased blood flow rate. CONCLUSIONS: Flow induced endothelium dependent arterial dilatation is not mediated by nitric oxide or, if nitric oxide is still released in response to flow rate increase, it has a source distinct from L-arginine.
No takes yet. Share an insight, caveat, or question.
Melkumyants et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: